Respiratory Syncytial Virus (RSV) Diagnostic Market by Share, Size, Revenue, Top Manufacturers and Forecast
A new Report by Delvens, titled "Respiratory Syncytial Virus (RSV) Diagnostic Market” offers a comprehensive analysis of the industry, which comprises insights on the Global analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market, the global Respiratory Syncytial Virus market size was estimated at USD 1.05 billion in 2023 and is projected to reach USD 2.2 billion in 2030 at a CAGR of 10.4% during the forecast period to 2030.
Get Free Sample Report: https://www.delvens.com/get-free-sample/respiratory-syncytial-virus-market
The respiratory virus known as respiratory syncytial virus (RSV) attacks the lungs and bronchioles. The majority of children become unwell from it by the age of two, making it one of the prevalent causes of childhood disease. Adults can also contract RSV. Pneumonia and bronchitis are among the more serious RSV infections. One of the main drivers of market expansion is the rising sickness rate.
Recent Developments
Allplex RV Master Assay acquired the European CE-IVD certification and clearance from Australia's Therapeutic Goods Administration, according to a release from Seegene Inc. in April 2022. It can discriminate between two kinds of respiratory syncytial viruses and 21 targets for 19 distinct respiratory viruses.
SARS-CoV-2, influenza A and B, respiratory syncytial virus, and Pandemic Response Lab (PRL), a wholly-owned subsidiary of Opentrons Labworks Inc., introduced a condensed respiratory panel in March 2022. (RSV).
The Prominent Players in the Respiratory Syncytial Virus (RSV) Diagnostic Market:
· BIOMERIEUX
· Abbott
· F. Hoffman La. Roche Ltd
· Danaher
· Thermo Fisher Scientific Inc.
· Luminex Corporation
· BioCartis, Hologic, Inc.
· Fast Track Diagnostics Luxembourg S.à r.l.
· Beckman Coulter Inc.
· Ortho-Clinical Diagnostics
· Bio-Rad Laboratories Inc.
· DiaSorin S.p.A.
· Becton, Dickinson and Company
· AbbVie, Inc.
· AstraZeneca PLC
· Atea Pharmaceuticals
· Bausch Health Companies Inc.
· Celltrion Inc.
· Enanta Pharmaceuticals, Inc and More
The Respiratory Syncytial Virus Market is segmented into various segments such as Product, Method, End User, Drug type, Dosage Form, Distribution channel, and region:
Based on Product
· Kits and Assays
· Instruments
· Others
Based on the Method
· Molecular Diagnostics
· Rapid Antigen Detection Tests
· Immunoassays
· Flow Cytometry
· Chromatography
· Others
Based on the End User
· Hospitals and Clinics
· Clinical Laboratories
· Others
Based on Drug type
· Ribavirin
· Synagis
· Virazole
· Palivizumab
· Riba Tab
· Others
Based on Dosage Form
· Oral
· Injectable
· Inhaler
· Other
Based on Distribution Channel
· Hospital pharmacies
· Drug Stores
· Retail pharmacies
· Clinics
Access Full Report: https://www.delvens.com/report/respiratory-syncytial-virus-market
In addition to the market data for the Respiratory Syncytial Virus Market, Delvens offers client-centric reports customized according to the company’s specific demand and requirements.
More Reports Form Delvens:
Sternal Closure Systems market
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.
Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact us:
Unit No. 01, 3rd Floor, Plot No. 56, Block B
Sector 2 Noida, Near Noida Sector 15 Metro Station 201301, IN
+44 20 3290 6466
+0120- 4903958
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian